Brian Joseph Cahill

All filings by Brian Joseph Cahill on record concern Eagle Pharmaceuticals, Inc., in the capacity of finance chief. We count 22 filings; the first trade dates from 18 December 2020 and the latest from 27 February 2024.

Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

Most recently, on 29 February 2024, the filings show a share grant worth €9,431 in Eagle Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.